NZ529097A - Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as GABA A receptor modulators - Google Patents

Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as GABA A receptor modulators

Info

Publication number
NZ529097A
NZ529097A NZ529097A NZ52909702A NZ529097A NZ 529097 A NZ529097 A NZ 529097A NZ 529097 A NZ529097 A NZ 529097A NZ 52909702 A NZ52909702 A NZ 52909702A NZ 529097 A NZ529097 A NZ 529097A
Authority
NZ
New Zealand
Prior art keywords
compound
formula
benzazepine
pyrimido
imidazo
Prior art date
Application number
NZ529097A
Other languages
English (en)
Inventor
Raffaello Masciadri
Andrew William Thomas
Juergen Wichmann
Original Assignee
F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F filed Critical F
Publication of NZ529097A publication Critical patent/NZ529097A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NZ529097A 2001-05-18 2002-05-08 Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as GABA A receptor modulators NZ529097A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01112222 2001-05-18
PCT/EP2002/005121 WO2002094834A1 (en) 2001-05-18 2002-05-08 Imidazo [1,5-a] pyrimido [5,4-d] benzazepine derivatives as gaba a receptor modulators

Publications (1)

Publication Number Publication Date
NZ529097A true NZ529097A (en) 2005-04-29

Family

ID=8177471

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ529097A NZ529097A (en) 2001-05-18 2002-05-08 Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as GABA A receptor modulators

Country Status (37)

Country Link
US (1) US6686352B2 (https=)
EP (1) EP1399448B1 (https=)
JP (1) JP4068466B2 (https=)
KR (1) KR100533406B1 (https=)
CN (1) CN1230436C (https=)
AR (1) AR033753A1 (https=)
AT (1) ATE283857T1 (https=)
AU (1) AU2002338898B2 (https=)
BG (1) BG108369A (https=)
BR (1) BR0209859A (https=)
CA (1) CA2446903C (https=)
CZ (1) CZ20033355A3 (https=)
DE (1) DE60202147T2 (https=)
DK (1) DK1399448T3 (https=)
EC (1) ECSP034851A (https=)
ES (1) ES2232778T3 (https=)
GT (1) GT200200087A (https=)
HR (1) HRP20030890A2 (https=)
HU (1) HUP0400743A3 (https=)
IL (2) IL158572A0 (https=)
JO (1) JO2297B1 (https=)
MA (1) MA27024A1 (https=)
MX (1) MXPA03010529A (https=)
MY (1) MY127570A (https=)
NO (1) NO20035104L (https=)
NZ (1) NZ529097A (https=)
PA (1) PA8545201A1 (https=)
PE (1) PE20030041A1 (https=)
PL (1) PL366846A1 (https=)
PT (1) PT1399448E (https=)
RU (1) RU2287531C2 (https=)
SI (1) SI1399448T1 (https=)
SK (1) SK15252003A3 (https=)
TW (1) TWI251489B (https=)
WO (1) WO2002094834A1 (https=)
YU (1) YU90003A (https=)
ZA (1) ZA200308544B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005243175B2 (en) 2004-05-14 2011-12-01 Millennium Pharmaceuticals, Inc. Compounds and methods for inhibiting mitotic progression by inhibition of Aurora kinase
CN102766142A (zh) * 2004-10-04 2012-11-07 千禧药品公司 有效作为蛋白激酶抑制剂的内酰胺化合物
AU2005299031B2 (en) 2004-10-20 2011-11-10 F. Hoffmann-La Roche Ag Halogen substituted benzodiazepine derivatives
MX2007004639A (es) * 2004-10-20 2007-06-08 Hoffmann La Roche Derivados de imidazo-benzodiazepina.
BRPI0617204A2 (pt) 2005-10-11 2011-07-19 Hoffmann La Roche derivados de imidazo benzodiazepina
PE20080145A1 (es) * 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
WO2009078999A1 (en) 2007-12-17 2009-06-25 Janssen Pharmaceutica N.V. Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1
CN101735211B (zh) * 2008-11-04 2012-11-14 复旦大学 2,3-二氢[1,5]苯并噻氮杂*类化合物或其盐在制备GSK-3β抑制剂中的用途
JP5684719B2 (ja) * 2008-12-05 2015-03-18 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Plk阻害剤としての5,7−ジヒドロ−6h−ピリミド[5、−4d][1]ベンゾアゼピン−6−チオン
RU2535032C2 (ru) 2008-12-22 2014-12-10 Милленниум Фармасьютикалз, Инк. Сочетание ингибиторов аврора киназы и анти-cd 20 антител
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
BR112012020557A8 (pt) 2010-02-19 2018-01-02 Millennium Pharm Inc formas cristalinas de 4-{[9-cloro-7-(2-flúor-6-metoifenil)-5h-pirimido[5,4-d][2]benzazepin-2-il]amino}-2-metoxibenzoato de sódio
CN101891706B (zh) * 2010-04-09 2013-05-29 复旦大学 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
CN102424670A (zh) * 2011-10-31 2012-04-25 江苏阿尔法药业有限公司 一种合成3-(3-氯丙基)-1,3,4,5-四氢-7,8-二甲氧基-2h-3-苯并氮杂卓-2-酮的方法
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
WO2014153509A1 (en) 2013-03-22 2014-09-25 Millennium Pharmaceuticals, Inc. Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase
NZ760341A (en) * 2013-12-20 2021-12-24 Agenebio Inc Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
MX392119B (es) 2015-06-19 2025-03-11 Agenebio Inc Derivados de benzodiazepina, composiciones y metodos para tratar deterioro cognitivo
WO2017015316A1 (en) 2015-07-21 2017-01-26 Millennium Pharmaceuticals, Inc. Administration of aurora kinase inhibitor and chemotherapeutic agents
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN112601749B (zh) 2018-06-19 2024-03-26 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂环庚三烯衍生物,组合物和方法
CN110452172B (zh) * 2019-08-21 2021-03-26 爱斯特(成都)生物制药股份有限公司 一种苯并己内酰胺的合成方法
CN112159411A (zh) * 2020-10-15 2021-01-01 南京工业大学 一种三氟甲基取代嘧啶并[1,3]二氮杂*化合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607503B1 (fr) * 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
TW201311B (https=) 1991-06-17 1993-03-01 Hoffmann La Roche
RU2119496C1 (ru) * 1992-04-14 1998-09-27 Научно-исследовательский институт фармакологии Российской академии медицинских наук Производные n-ацилпролилдипептидов
FR2728902B1 (fr) * 1994-12-29 1997-01-31 Synthelabo Derives d'acide 8-oxo-5,8-dihydro-6h-dibenzo(a,g)quinolizine-13-propanoique, leur preparation et leur application en therapeutique
US6166203A (en) * 1998-02-26 2000-12-26 Neurogen Corporation Heterocyclic amino substituted heteroaryl fused pyridines; GABA brain receptor ligands
US6177569B1 (en) * 1998-08-25 2001-01-23 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
FR2783828B1 (fr) 1998-09-29 2000-11-10 Synthelabo Derives d'acide 5,6-dihydro-4h-imidazo[1,2-a][1] benzazepine -1-acetique, leur preparation et leur application en therapeutique
CA2388593A1 (en) 1999-11-12 2001-05-17 Neurogen Corporation Bicyclic and tricyclic heteroaromatic compounds
TWI239333B (en) 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators

Also Published As

Publication number Publication date
DE60202147D1 (de) 2005-01-05
HRP20030890A2 (en) 2005-08-31
WO2002094834A1 (en) 2002-11-28
PL366846A1 (en) 2005-02-07
EP1399448B1 (en) 2004-12-01
JP4068466B2 (ja) 2008-03-26
RU2003136078A (ru) 2005-05-27
CN1509289A (zh) 2004-06-30
ECSP034851A (es) 2003-12-24
ZA200308544B (en) 2005-01-31
MXPA03010529A (es) 2004-03-02
SK15252003A3 (sk) 2004-08-03
ATE283857T1 (de) 2004-12-15
PE20030041A1 (es) 2003-02-07
PA8545201A1 (es) 2003-02-28
NO20035104D0 (no) 2003-11-17
HK1066544A1 (en) 2005-03-24
BG108369A (bg) 2005-01-31
IL158572A0 (en) 2004-05-12
AR033753A1 (es) 2004-01-07
CZ20033355A3 (en) 2004-07-14
PT1399448E (pt) 2005-03-31
HUP0400743A2 (hu) 2004-07-28
BR0209859A (pt) 2004-06-15
US6686352B2 (en) 2004-02-03
US20030055042A1 (en) 2003-03-20
DK1399448T3 (da) 2005-04-11
GT200200087A (es) 2003-06-19
AU2002338898B8 (en) 2002-12-03
ES2232778T3 (es) 2005-06-01
EP1399448A1 (en) 2004-03-24
SI1399448T1 (en) 2005-02-28
KR20040002975A (ko) 2004-01-07
YU90003A (sh) 2006-08-17
NO20035104L (no) 2003-11-17
AU2002338898B2 (en) 2007-03-15
DE60202147T2 (de) 2005-12-01
CA2446903A1 (en) 2002-11-28
KR100533406B1 (ko) 2005-12-02
JO2297B1 (en) 2005-09-12
CN1230436C (zh) 2005-12-07
RU2287531C2 (ru) 2006-11-20
CA2446903C (en) 2008-12-30
JP2004531563A (ja) 2004-10-14
IL158572A (en) 2010-02-17
HUP0400743A3 (en) 2007-09-28
TWI251489B (en) 2006-03-21
MY127570A (en) 2006-12-29
MA27024A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
NZ529097A (en) Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as GABA A receptor modulators
AU2002338898A1 (en) Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as GABA A receptor modulators
US6743789B2 (en) Substituted imidazo[1,5-a][1,2,4]triazolo[4,3-d][1,4]benzodiazepine derivatives
RU2139873C1 (ru) Имидазодиазепины, способ их получения и лекарственное средство
AU2002217007A1 (en) Benzodiazepine derivatives as GABA A receptor modulators
JPH078869B2 (ja) イミダゾジアゼピン誘導体類
NZ554556A (en) Halogen substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepines
KR0157068B1 (ko) 신규 3- 옥사디아졸릴-1,6-나프티리딘 유도체
TW202202495A (zh) 作為gamma-胺基丁酸A受體次單元alpha 5受體調節劑之㖠啶及吡啶并〔3,4-c〕嗒𠯤衍生物
JP2673654B2 (ja) テトラヒドロ−1,6−ナフチリジン誘導体およびその塩
JPH11279176A (ja) 1,2,4−オキサジアゾリルキノロン誘導体
JPH0710874A (ja) 3−(1,2,4−オキサジアゾリル)−5,6,7,8−テトラヒドロ−1,6−ナフチリジン誘導体

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)